PMID- 38169464 OWN - NLM STAT- MEDLINE DCOM- 20240109 LR - 20240116 IS - 1643-3750 (Electronic) IS - 1234-1010 (Print) IS - 1234-1010 (Linking) VI - 30 DP - 2024 Jan 3 TI - Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 (MCP-1) and 28-Day Mortality in Elderly Patients with Sepsis: A Retrospective Single-Center Study. PG - e942079 LID - 10.12659/MSM.942079 [doi] AB - BACKGROUND Previous studies have identified an association between plasma levels of the inflammatory cytokine, monocyte chemoattractant protein-1 (MCP-1), and outcomes for patients with sepsis. This retrospective single-center study assessed the association between plasma levels of MCP-1 and 28-day mortality in 136 patients >/=65 years diagnosed with sepsis between October 2020 and October 2021. MATERIAL AND METHODS The objective was to compare and analyze the parameters in the survival group (n=35) and the 28-day mortality group (n=101), including Sequential Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health Evaluation II (APACHE II), plasma MCP-1, and laboratory test results. Plasma MCP-1 was quantified by cytokine test kit (LKTM014B, R&D). Statistical analysis was carried out in SPSS 26.0 and MedCalc 92.1.0 software. RESULTS The 28-day mortality group exhibited higher levels of SOFA, APACHEII, and plasma MCP-1 (all P<0.001), as well as lower levels of albumin, compared to the survival group (P<0.05). The logistic regression analysis findings indicated that SOFA, APACHEII, plasma MCP-1, and SBP are all independent risk factors for 28-day mortality. The area under the curve for SOFA, APACHEII, MCP-1, MCP-1+ SOFA, and MCP-1+APACHEII were 0.845, 0.744, 0.712, 0.879, and 0.822, respectively. MCP-1+SOFA exhibited higher sensitivity than SOFA alone. Furthermore, the assessment values of plasma MCP-1 combined with SOFA were superior to those of APACHE II or plasma MCP-1 (Z(1)=2.661, Z(2)=3.272, both P<0.01). CONCLUSIONS The findings from this study from a single center support those of previous studies that increased plasma levels of MCP-1 are significantly associated with 28-day mortality in patients with sepsis. FAU - Duan, Yunjiao AU - Duan Y AUID- ORCID: 0000-0001-8699-8470 AD - Department of Emergency, Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, and Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation. Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China (mainland). FAU - Liu, Min AU - Liu M AD - Department of Emergency, Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, and Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation. Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China (mainland). FAU - Wang, Junyu AU - Wang J AD - Department of Emergency, Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, and Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation. Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China (mainland). FAU - Wei, Bing AU - Wei B AD - Department of Emergency, Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, and Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation. Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China (mainland). LA - eng PT - Journal Article DEP - 20240103 PL - United States TA - Med Sci Monit JT - Medical science monitor : international medical journal of experimental and clinical research JID - 9609063 RN - 0 (Chemokine CCL2) RN - 0 (CCL2 protein, human) SB - IM MH - Aged MH - Humans MH - *Chemokine CCL2 MH - Intensive Care Units MH - Organ Dysfunction Scores MH - Prognosis MH - Retrospective Studies MH - ROC Curve MH - *Sepsis PMC - PMC10773152 COIS- Conflict of interest: None declared EDAT- 2024/01/04 01:18 MHDA- 2024/01/05 06:42 PMCR- 2024/01/03 CRDT- 2024/01/03 11:37 PHST- 2024/01/05 06:42 [medline] PHST- 2024/01/04 01:18 [pubmed] PHST- 2024/01/03 11:37 [entrez] PHST- 2024/01/03 00:00 [pmc-release] AID - 942079 [pii] AID - 10.12659/MSM.942079 [doi] PST - epublish SO - Med Sci Monit. 2024 Jan 3;30:e942079. doi: 10.12659/MSM.942079.